Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Veng-Pedersen

Showing results (71-80 of 103) with videos related to

Pageof 11
Sort By:
Biopharmaceutics & Drug Disposition|October 20, 2000
Carbamazepine level-A in vivo-in vitro correlation (IVIVC): a scaled convolution based predictive approachP Veng-Pedersen, J V Gobburu, M C Meyer, et al.
Experimental Hematology|April 13, 2001
Receptor-based model accounts for phlebotomy-induced changes in erythropoietin pharmacokineticsS H Chapel, P Veng-Pedersen, R L Schmidt, et al.
Pharmaceutical Research|October 2, 1998
Correction for non-ideal tracer pharmacokinetic disposition by disposition decomposition analysis (DDA)P Veng-Pedersen, S S Hong, J A Widness, et al.
Journal of Pharmaceutical Sciences|July 1, 1993
Application of a system analysis approach to population pharmacokinetics and pharmacodynamics of nicardipine hydrochloride in healthy malesN B Modi, P Veng-Pedersen, D J Graham, et al.
The Journal of Laboratory and Clinical Medicine|July 1, 1982
Theophylline elimination in the pregnant and fetal rabbitR E Brashear, P Veng-Pedersen, M L Rhodes, et al.
The Journal of Burn Care & Rehabilitation|March 1, 1994
Pharmacokinetics of morphine sulfate in patients with burnsR A Herman, P Veng-Pedersen, J Miotto, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 28, 2004
Pharmacokinetic/pharmacodynamic analysis of paradoxal regulation of erythropoietin production in acute anemiaN H Al-Huniti, J A Widness, R L Schmidt, et al.
Journal of Pharmaceutical Sciences|February 1, 1989
Pharmacokinetics of low-dose methotrexate in rheumatoid arthritis patientsR A Herman, P Veng-Pedersen, J Hoffman, et al.
Biopharmaceutics & Drug Disposition|November 6, 2004
Erythropoietin production rate in phlebotomy-induced acute anemiaN H Al-Huniti, J A Widness, R L Schmidt, et al.
Journal of Pharmaceutical Sciences|September 1, 1995
Duration of opioid antagonism by nalmefene and naloxone in the dog: an integrated pharmacokinetic/pharmacodynamic comparisonP Veng-Pedersen, J A Wilhelm, T B Zakszewski, et al.
Pageof 11

Showing results (71-80 of 103) with videos related to

Sort By:
Pageof 11
Biopharmaceutics & Drug Disposition|October 20, 2000
Carbamazepine level-A in vivo-in vitro correlation (IVIVC): a scaled convolution based predictive approachP Veng-Pedersen, J V Gobburu, M C Meyer, et al.
Experimental Hematology|April 13, 2001
Receptor-based model accounts for phlebotomy-induced changes in erythropoietin pharmacokineticsS H Chapel, P Veng-Pedersen, R L Schmidt, et al.
Pharmaceutical Research|October 2, 1998
Correction for non-ideal tracer pharmacokinetic disposition by disposition decomposition analysis (DDA)P Veng-Pedersen, S S Hong, J A Widness, et al.
Journal of Pharmaceutical Sciences|July 1, 1993
Application of a system analysis approach to population pharmacokinetics and pharmacodynamics of nicardipine hydrochloride in healthy malesN B Modi, P Veng-Pedersen, D J Graham, et al.
The Journal of Laboratory and Clinical Medicine|July 1, 1982
Theophylline elimination in the pregnant and fetal rabbitR E Brashear, P Veng-Pedersen, M L Rhodes, et al.
The Journal of Burn Care & Rehabilitation|March 1, 1994
Pharmacokinetics of morphine sulfate in patients with burnsR A Herman, P Veng-Pedersen, J Miotto, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 28, 2004
Pharmacokinetic/pharmacodynamic analysis of paradoxal regulation of erythropoietin production in acute anemiaN H Al-Huniti, J A Widness, R L Schmidt, et al.
Journal of Pharmaceutical Sciences|February 1, 1989
Pharmacokinetics of low-dose methotrexate in rheumatoid arthritis patientsR A Herman, P Veng-Pedersen, J Hoffman, et al.
Biopharmaceutics & Drug Disposition|November 6, 2004
Erythropoietin production rate in phlebotomy-induced acute anemiaN H Al-Huniti, J A Widness, R L Schmidt, et al.
Journal of Pharmaceutical Sciences|September 1, 1995
Duration of opioid antagonism by nalmefene and naloxone in the dog: an integrated pharmacokinetic/pharmacodynamic comparisonP Veng-Pedersen, J A Wilhelm, T B Zakszewski, et al.
Pageof 11